BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38566803)

  • 1. Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma.
    Merryman RW; Rhoades J; Xiong K; Redd RA; Antel K; An HH; McDonough M; Guerrero L; Crnjac A; Sridhar S; Blewett T; Cheng J; Dahi PB; Nieto Y; Joyce RM; Chen YB; Herrera AF; Armand P; Murakami M; Adalsteinsson VA
    Hemasphere; 2024 Apr; 8(4):e47. PubMed ID: 38566803
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.
    Roschewski M; Dunleavy K; Pittaluga S; Moorhead M; Pepin F; Kong K; Shovlin M; Jaffe ES; Staudt LM; Lai C; Steinberg SM; Chen CC; Zheng J; Willis TD; Faham M; Wilson WH
    Lancet Oncol; 2015 May; 16(5):541-9. PubMed ID: 25842160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.
    Sun R; Zheng Z; Wang L; Cheng S; Shi Q; Qu B; Fu D; Leboeuf C; Zhao Y; Ye J; Janin A; Zhao WL
    Mol Oncol; 2021 Jan; 15(1):246-261. PubMed ID: 33107145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-Matched IgH Gene Rearrangement of Circulating Tumor DNA Shows Significant Value in Predicting the Progression of Diffuse Large B Cell Lymphoma.
    Zhao K; Zheng X; Liu X; Liu T; Ke Z; Zhu F; Wen Q; Xin B; Li Q; Zhang L
    Oncologist; 2024 May; 29(5):e672-e680. PubMed ID: 38297976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Application and Research Progress of Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma--Review].
    Zhang HY; Yang YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1917-1921. PubMed ID: 36476926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genomic analysis of temozolomide resistance in diffuse large B-cell lymphoma.
    Leshchenko VV; Kuo PY; Jiang Z; Thirukonda VK; Parekh S
    Clin Cancer Res; 2014 Jan; 20(2):382-92. PubMed ID: 24178621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma.
    Wu FT; Lu L; Xu W; Li JY
    Ann Hematol; 2019 Feb; 98(2):255-269. PubMed ID: 30368587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.
    Haider Z; Wästerlid T; Spångberg LD; Rabbani L; Jylhä C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hägglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
    Front Oncol; 2023; 13():1176698. PubMed ID: 37333831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype.
    Yoshida S; Nakamura N; Sasaki Y; Yoshida S; Yasuda M; Sagara H; Ohtake T; Takenoshita S; Abe M
    Mod Pathol; 2005 Mar; 18(3):398-405. PubMed ID: 15492762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary diffuse large B cell lymphoma of the stomach: analysis of somatic mutations in the rearranged immunoglobulin heavy chain variable genes indicates antigen selection.
    Driessen A; Tierens A; Ectors N; Stul M; Pittaluga S; Geboes K; Delabie J; De Wolf-Peeters C
    Leukemia; 1999 Jul; 13(7):1085-92. PubMed ID: 10400425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deviated VH4 immunoglobulin gene usage is found among thyroid mucosa-associated lymphoid tissue lymphomas, similar to the usage at other sites, but is not found in thyroid diffuse large B-cell lymphomas.
    Sato Y; Nakamura N; Nakamura S; Sakugawa S; Ichimura K; Tanaka T; Ohara N; Oka T; Kondo E; Yoshino T
    Mod Pathol; 2006 Dec; 19(12):1578-84. PubMed ID: 16980947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between baseline
    Decazes P; Camus V; Bohers E; Viailly PJ; Tilly H; Ruminy P; Viennot M; Hapdey S; Gardin I; Becker S; Vera P; Jardin F
    EJNMMI Res; 2020 Oct; 10(1):120. PubMed ID: 33029662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression.
    Valera A; Epistolio S; Colomo L; Riva A; Balagué O; Dlouhy I; Tzankov A; Bühler M; Haralambieva E; Campo E; Soldini D; Mazzucchelli L; Martin V
    Mod Pathol; 2016 Aug; 29(8):844-53. PubMed ID: 27125356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Application of Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma--Review].
    Chen XF; Wang M; Zhang F; Li JJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):638-642. PubMed ID: 33812444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.
    Scherer F; Kurtz DM; Newman AM; Stehr H; Craig AF; Esfahani MS; Lovejoy AF; Chabon JJ; Klass DM; Liu CL; Zhou L; Glover C; Visser BC; Poultsides GA; Advani RH; Maeda LS; Gupta NK; Levy R; Ohgami RS; Kunder CA; Diehn M; Alizadeh AA
    Sci Transl Med; 2016 Nov; 8(364):364ra155. PubMed ID: 27831904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma.
    Hu R; Winter A; Hill BT
    Curr Oncol Rep; 2019 Apr; 21(5):44. PubMed ID: 30941515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma.
    Alcaide M; Yu S; Bushell K; Fornika D; Nielsen JS; Nelson BH; Mann KK; Assouline S; Johnson NA; Morin RD
    Clin Chem; 2016 Sep; 62(9):1238-47. PubMed ID: 27440511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the feasibility and prognostic value of circulating tumor DNA monitoring in detecting gene mutations in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy].
    Zhou LH; Feng YQ; Hu YX; Huang H
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):805-812. PubMed ID: 38049331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of different protein expression levels in peripheral blood circulating tumor cells from patients with diffuse large B-cell lymphoma and their predictive efficiency for recurrence].
    Wang C; Zhou X; Liu GY; Qu CY; Yuan CY; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(17):1328-1333. PubMed ID: 37150683
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-free DNA for detection of clonal B cells in diffuse large B cell lymphoma by sequencing.
    Højlund EL; Cédile O; Larsen TS; Vimalathas G; Møller MB; Hansen MH; Nyvold CG
    Int J Lab Hematol; 2023 Oct; 45(5):735-742. PubMed ID: 37350020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.